Inhaled anesthetics
PreclinicalSmall molecule
Inhaled anesthetics is one of 40 small molecule programs targeting Memory. It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
39
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
48 competitors in Memory
#DrugCompanyPhaseTrials
1Aricept
EisaiApproved
Myrbetriq
AstellasApproved
Ritalin
NovartisApproved
Inderal
WWyeth-Lederle Vaccines
Approved
Ambien
PPurdue Pharma LP
Approved
Intuniv
PPromius Pharma, LLC
Approved
Mifeprex
DDanco
Approved
Nuvigil
NNuvo Research GmbH
Approved
Rilutek
AAzurity Pharmaceuticals
Approved
Bendopa
MMerz North America, Inc.
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Memory1 trial
Memory During Inhalation Anesthesia Performed With or Without Bispectral Index (BIS) in Patients Undergoing Thyroidectomy
Unknown status·—··NCT01146431·130 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Inhaled anesthetics. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SSamsung Medical Center